Pharmacy Podcast Network

Children & COVID 19 Vaccines | The Pediatric Pharmacist Review

We launch the first podcast episode of the Pediatric Pharmacist Review, with our host Dr. Allison Chung, PharmD & Pediatric Critical Care Pharmacist, BCPPS Certified at University of South Alabama Health. 
Guest: Dr. Benjamin Estrada
Topic: COVID 19 vaccines in pediatrics: 
How the different COVID vaccines work.
Current information and research on the vaccine’s safety and efficacy in pediatric patients.
Has it been tested to the same extent that other vaccines are tested on children?
Will the COVID vaccine recommendations include patients younger than 14? When do we think this will happen?
What do you say to people who understand that younger patients are less likely to get COVID and less severe symptoms so therefore do not want their children to receive the vaccine?
Long term affects of the COVID vaccine on children. Any potential for autism or infertility?
Risk vs benefit of COVID vaccine vs getting COVID in children. Many people feel the risk of getting the vaccine is worse because the risk for COVID in children is less and severity of COVID symptoms are less than adults.
Suggestions for how pharmacists can encourage vaccination in the pediatric population.
At the F.D.A.’s urging, Pfizer-BioNTech and Moderna are expanding their trials for children 5 to 11.
NYT: https://www.nytimes.com/2021/07/26/us/politics/fda-covid-vaccine-trials-children.html
At the urging of federal regulators, two coronavirus vaccine makers are expanding the size of their clinical trials for children ages 5 to 11 — a precautionary measure designed to detect rare side effects including heart inflammation problems that turned up in vaccinated people younger than 30.
President Biden promised at a meeting in Ohio last week that emergency clearance for pediatric vaccines would come “soon,” but the White House has not been specific on the timeline. It was unclear whether expanding the studies will affect when vaccines could be authorized for children.
The Food and Drug Administration has indicated to Pfizer-BioNTech and Moderna that the size and scope of their pediatric studies, as initially envisioned, were inadequate to detect rare side effects. Those include myocarditis, an inflammation of the heart muscle, and pericarditis, inflammation of the lining around the heart, multiple people familiar with the trials said.
Questions about vaccinating children — including those under 12 — are of huge interest to parents and teachers. Regulators will be required to balance potential side effects of coronavirus vaccination against the risks of Covid-19.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacist’s Impact on Ending Asian Hate | Transforming a Nation

The horrific story of a gunman killing eight people at three Atlanta-area spas earlier this year; six of the victims were women of Asian descent, sparking fears among advocacy groups that the killings may have been racially motivated.
Anti-Asian hate crimes have spiked 150 percent since the pandemic began, according to a recent study.
Suspect charged with killing 8 in Atlanta-area shootings that targeted Asian-run spas
People of Asian descent have been living in the United States for more than 160 years, and have long been the target of bigotry. Transforming the Nation tackles this sociological & community issue head on. It's up to us to End Asian Hate. 
Our special guests:  
Shin-Yu Lee, PharmD, BCPS, BCACP - sylee.rx@gmail.com; https://www.linkedin.com/in/shin-yu-l-p-ab2427213
Bonnie Hui-Callahan, PharmD, CDCES - bonnie.c.hui@gmail.com; https://www.linkedin.com/in/bonnie-hui-callahan
Free compiled list of resources for AAPI community and allies: www.theclinicianleader.com/ally 
The Clinician-Leader: www.theclinicianleader.com; LinkedIn, Instagram, and Facebook 
Additional Resources: 
NEJM - Practical Guide for Combating Anti-Asian Sentiment - https://www.nejm.org/doi/full/10.1056/NEJMp2102656
https://stopaapihate.org/ - tracks and responds to incidents of hate, violence, harrasment, and discrimination against AAPI
www.aapidata.com - demographic data and policy research on AAPI
www.standagainsthatred.org
https://ahi.ucsf.edu/advocacy/resources - Asian Health Institute
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

A New Procurement Model of Brand Name Drugs | RxRise

Transforming Pharmaceutical Obsolescence into Opportunity
RxRise is a revolutionary marketplace platform that lists pharmaceutical manufacturers short-dated and surplus stock directly to pharmacies.
Bringing together today’s leaders in the worlds of healthcare and pharmaceuticals.
We are hyper aware of the impact that short-dated and surplus drugs have on our industry and our planet. It’s not good for business, the environment or society. That’s why we’ve pooled our knowledge in healthcare and technology to find an innovative solution that could check all the boxes. In other words, help both manufacturers and pharmacies do good and make an impact. 
Our guest, Adam Gladieux Founder and CEO at RxRise, joined Todd Eury at Pharmacy Podcast Network Studios HQ in Hiller Pennsylvania, approximately 45 miles south of Pittsburgh, PA.  
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The RxBLU Difference | RxBLU CloudCast

Pharmacy: El Tejon Pharmacy Frazier Park Interviewee: Ty Stout, PharmD., Pharmacist in Charge Ty purchased an Eyeconn pill counter before consulting with the RxBLU team and they quickly created a bi-directional interface for the technology. Script Pro charges thousands of dollars for easy & quick enhancements and reports, but RxBLU does not. Ty is a young advocate of Independent pharmacy and he is on the board with PFOA Buying Group. https://www.pfoai.org/ The el Tejon Pharmacies have served Bakersfield and Kern County since 1928. Their team leverages over 80 years of combined experience to meet the health and wellness needs of their communities. About RxBLU: Based in Southern California, Cypress Software, Inc. is a team of developers, pharmacists and pharmacy owners with more than a century of combined industry experience. This diverse team created RxBLU™ because they wanted to make a real difference for hardworking pharmacists and their staff. By providing software that is built upon the pharmacy operator's ideas, the RxBLU developers make it easy for their clients to serve their patients no matter the circumstances. When it comes to pharmacy software, too much of it is outdated except for changes required by law. It makes it possible for you to get by, but there’s no reason to settle for that. Instead, choose to become a leader with our cutting-edge software. Thanks to its innovative and customizable nature, our software can help in a diverse array of applications while performing consistently and securely. See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacist & Physician Opioid Collaborative | Part Three: Pharmacists leading Pain Management Improves Patient Satisfaction of Treatment | William Ama...

From a published journal article from the American Journal of Health System Pharmacy, the data highlights the impact of a pharmacist directed pain management treatment plan within institutional opioid use. The report noted that with the pharmacist lead treatment there was improved patient satisfaction scores and indirect cost savings.
Despite decreased opioid use, available patient satisfaction data suggested ongoing improvement in associated with pharmacist designed pain management plans.
Today we continue to build upon the podcast series called:
Pharmacists & Physicians Working Together for Responsible Opioid Usage
Special guest:
William Amarquaye, PharmD
Clinical Pharmacist at Florida Regional Hospital
Impact of a pharmacist-directed pain management service on inpatient opioid use, pain control, and patient safety
https://academic.oup.com/ajhp/article-abstract/76/1/17/5257115?redirectedFrom=fulltext
The CDC Opioid Guideline: Proponent Interpretation Has Led to Misinformation
https://pubmed.ncbi.nlm.nih.gov/29608033/
Quantifying the Epidemic of Prescription Opioid Overdose Deaths
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844400/
CDC's Efforts to Quantify Prescription Opioid Overdose Deaths Fall Short
https://pubmed.ncbi.nlm.nih.gov/33761120/
An Examination of State and Federal Opioid Analgesic and Continuing Education Policies: 2016–2018
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534855/
CDC Advises Against Misapplication of the Guideline for Prescribing Opioids for Chronic Pain
https://www.cdc.gov/media/releases/2019/s0424-advises-misapplication-guideline-prescribing-opioids.html 
This episode is sponsored by the Ultiguard Safe Pack. UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy., 
Learn more about the UltiGuard Safe Pack: 
https://www.ulticare.com/ultiguard-safe-pack/podcast
#PROPRx
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Advancing Healthcare Leadership - Holding Space and Advocating for Women in Pharmacy Leadership | The Public Health Pharmacist

Hillary Blackburn, PharmD, MBA
Dr. Blackburn is a clinically and business trained pharmacist who's been practicing for almost a decade in a variety of healthcare settings. She has experience in healthcare strategy, business development, formulary development and management, consulting, and establishing successful medication access programs. In her current role, she serves as the Director of Pharmaceutical Services at Dispensary of Hope, a national non-profit medication distributor hosted by Ascension where she oversees the formulary, leads research initiatives, and manages the network of strategic advisors on Dispensary of Hope's Pharmacy Advisory Council.
Dr. Blackburn was selected to serve in a national leadership position on the American Pharmacists Association's (APhA) - APPM Executive Committee for 2021-2022. Additionally, she serves as Co-Chair for the Advocacy Committee for APhA's Care of the Underserved Special Interest Group and as a member of the Membership Engagement and Legislative and Policy committees for the Tennessee Pharmacist Association. Dr. Blackburn also precepts Belmont University College of Pharmacy student pharmacists and serves on the Dean's External Advisory Committee. Dr. Blackburn is a graduate of the University of Mississippi School of Pharmacy and completed a PGY1 Pharmacy Practice Residency at the University of Mississippi Medical Center.
Hillary is passionate about promoting the pharmacy profession and delivering expert patient care which led her to found the Pharmacy Advisory Group which provides pharmacy expertise in consulting and education. Her popular podcast, Talk to Your Pharmacist, has over 170 episodes highlighting successful pharmacy leaders and sharing about current healthcare trends. In 2012, Hillary returned to her Tennessee roots and met her wonderful husband, Chad, in Nashville where she enjoys staying involved in her community through volunteering, living an active lifestyle, traveling, spending time with friends and family, and welcoming their baby girl in August 2020.
In October 2020, she released her first book titled How Pharmacists Lead: Answers from Women Who Are Leading, Succeeding, and Impacting Pharmacy which is available on Amazon here.
SOCIALS:
Founder & Podcast Host, Talk to Your Pharmacist
Author, How Pharmacists Lead
Instagram@TalktoYourPharmacist; Twitter@HillBlackburn; Facebook
www.hillaryblackburn.com 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID Keto Guido | PAIN POD

On this episode of the PAIN POD, Mark Pain Guy Garofoli will take you on a journey of a pain guy in pain, and just what our patients hear from us as healthcare professionals, and what the healthcare system experience can be like when not being the one wearing the stethoscope, and rather being the patient in pain.
Can anyone imagine being dropped off at the ER by your Wife and toddler on Friday the 13th during a pandemic to only begin a 3 month long excruciating journey of pain? Pain Guy Garofoli can tell you all about it, and provide a few clinical pearls to improve patient care along the way! This is not a campfire conversation, but you can feel free to download and listen while camping, swimming, biking, walking, or however, you’d like, just be forewarned that Mark will not be sparing any painful details. You’re welcome and he’s sorry, all at once!
COVID & NSAIDs Info
https://www.bbc.com/news/51929628
Jeong HE, et al. Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study. Clin Infect Dis. 2020 Jul 27.
https://clinicaltrials.gov/ct2/show/record/NCT04334629
NSAID COX-1 & COX-2 Studies
Feldman, M, et al. Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity. Ann Intern Med. 2000; 132: 134-143
Herndon, C. et al. Management of Chronic Nonmalignant Pain with Nonsteroidal Anti-inflammatory Drugs. Pharmacotherapy. 2008; 28 (6): 788-805.
Masso Gonzalez EL, et al. Variability among nonsteroidal anti-inflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 2010; 62: 1592-601.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

USP 800: Budgeting for People, Place & Practices

USP 800: Budgeting for the Build 
We all know that the adoption of USP 800 has been banging around for what seems like ages. I have been talking to people like Bryan about it for over a year. Bryan and I specifically have been discussing the budgeting issues and misconceptions there are regarding upgrading to USP 800, so I was particularly excited to do this podcast.
I think it’s a really important issue and I believe that 503A really need to start moving towards USP 800 compliance but need a realistic idea of the process and what that is going to cost them.  In addition to our conversation about t the budgeting issues I think one of my biggest takeaways was the need to work as a  unified team and have an experienced team leader.
Support the show (https://www.buymeacoffee.com/pharmasalon)
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

HIMSS 2021 Review | Be the Change

Dr. Christina Madison, the Public Health Pharmacist and Todd Eury, CEO of the Pharmacy Podcast Network attended the HIMSS conference in Las Vegas and had the opportunity to interview several dynamic companies focused on healthcare information technology & it’s impact on better patient care. 
HIMSS is the Healthcare Information and Management Systems Society, which is a global advisor, thought leader and member association committed to transforming the health ecosystem. The HIMSS 2021 Global Conference was attended by more than 20,000 participants and offers a unique depth and breadth of expertise in health innovation, public policy, research and analytics to advise leaders and influencers on best practices in modern healthcare delivery.
Special guests: 
Robert Cohen 
Jay Sultan
Collin Banas
Tina Moen 
Casey Pittolk & Mike Vidmar
Nick Potts 
Michelle Trombetta 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

HISTORY- The Pharmacopoeia | Lets Pharmonize

The Pharmacopoeia, oft taken for granted, has been through many major changes over the past few centuries. Mickey Ferguson takes us back to the ancient origins of what we now know as the pharmacopoeia.
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane, Mickey, and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health.
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional music and sound by Fesliyan Studios.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Innovative Roles of Pharmacy Technicians | OnScript

In this episode of On Script, Jeremy and special guest co-host, Lyndsey McDonald, Director of Retail Pharmacy Relationships at NHA, have a discussion with Raymond McCall, Chief Strategy Officer for Medly Pharmacy. 
Raymond discusses Medly’s unique business model, merging technology and pharmacy practice to deliver innovative patient care, and how they leverage pharmacy technicians as one of their foundational cornerstones to deliver the best possible customer service.  Additionally, Raymond shares a little bit about Medly’s ambitious growth aspirations to serve patients all across the US, and the importance of staffing highly trained pharmacy technicians and giving them opportunities to grow professionally within the Medly organization. 
If you’re a pharmacy professional looking for new opportunities to join an innovative company, be sure to check their Careers page often as Medly rapidly expands to new markets near you.  You don’t want to miss this episode!
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Get Ready for Data-Driven Medication Management | The Future of Pharmacy Podcast

Pharmacy dashboards are no longer enough. To manage organizational complexity and make better informed decisions, pharmacy leaders need dynamic intelligence tools. Learn how emerging technologies, including predictive and prescriptive analytics, can take medication management to the next level.
Guests:                     
Jennifer Tryon, PharmD, MS, FASHP, Associate Vice President and Chief Pharmacy Officer, Wake Forest Baptist Health
Allen Flynn, PharmD, PhD, Assistant Professor, Department of Learning Health Science, University of Michigan Medical School
Host:                         
Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Henry Agyeman PharmD., BSc | PharmGradWishList Podcast

Caroline L. Ko, PharmD, BCPS, BCCCP, co-founder of the PharmGradWishList interviews Henry Agyeman PharmD., BSc. Dr. Agyeman grew up in Ghana and moved to the US to pursue an undergraduate degree in Chemistry from VCU. His desire to help people led him to pursue the pharmacy profession. He just graduated from the University of Cincinnati with his PharmD degree and will be relocating from Ohio to Virginia to begin a PGY1 residency with VCU and Publix. The #PharmGradWishlist community will be raising funds to help with his moving costs and licensing fees as he will be required to be licensed in both Virginia and Florida for his residency. He aspires to be an accessible community health professional to provide optimal medication therapy and care for his patients. Henry Agyeman moving fund #PharmGradwishlist https://www.gofundme.com/f/henry-agyeman-moving-fund-pharmgradwishlist Dr. Agyeman is thankful for the generous support of the pharmacy community to help him into the next stage of his career. He is being sponsored by the #PharmGradWishList movement (@PharmWishList) to get the word out about his support. See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

POP CULTURE: Fear Street | Lets Pharmonize

Description: Horror movies haven't been known for their meticulous research into physiology and pharmacology. However, the effects of the events in Fear Street: Part 1 - 1994 may surprise you. In this episode we'll discuss, antiarrhythmics, opioids, and epipens, and what happens when you have the ultimate pharmacy cocktail.  
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane, Kelly and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health.
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
Additional music and sound by Fesliyan Studios.
This episode is sponsored by the Ultiguard Safe Pack. UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy., 
Learn more about the UltiGuard Safe Pack: 
https://www.ulticare.com/ultiguard-safe-pack/podcast
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

ASHP on CMS Pass Through Funding | PolitalkRx

Tom Kraus VP, Government Relations at ASHP 
CMS pass through funding
What is pass through funding for residency programs and why is it so important?
On March 29th the US District Court of South Carolina granted MUSC Health’s motion for summary judgment again HHS for their disallowance of PGY1 residency costs.  Can you provide some details/background on this case?  What was the guidance that CMS was failing to provide?
Can speak about ASHP’s work with CMS to make the guidance more apparent to other programs moving forward?
What will be the downstream effect of this case on residency programs in the future?
Can you break down the practice for our listeners?
What are the concerns with white bagging?
What are the steps being taken at the state and federal level to take action to the concerns related to white bagging?
Co-signing letter to the FDA
Leveraging PELA and SPPL; can you explain?
Partnership with AHA
Provider status
Can you talk about the work ASHP has done to ensure that pharmacists can provide Medication-assisted treatment (MAT)?
At the end of April the US House and Senate introduced the Pharmacy and Medically Underserved Areas Enhancement Act.  A similar bill has been submitted for the past couple of years.  Can you walk us through the history of this bill? What it would allow pharmacists to do? Why it is so important for the Country?  Statistics?
This bill continues to have bipartisan support.  What do we need to do as pharmacists to finally get this passed?
COVID-19 and its effect on provider status and Advocacy
Since the start of COVID-19 we’ve seen congress put forth bills and amendments that outline the healthcare response to the pandemic.  One such amendment to the PREP Act outlined that “any physician, advanced practice registered nurse, registered nurse, or practical nurse” who had a license within the last 5 years could participate in the vaccination effort, even if the license was inactive.  Pharmacists were left out of this amendment originally.  I believe that has since been updated, but what is it that we need to be doing as individuals within the profession to help government officials to understand the worth of pharmacists and consider them as a primary focus in any further legislation?
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Good Things Happening in Pharmacy | Pharmacy Crossroads

Good things are happening in pharmacy.  That is the core message of this podcast.  Becky Snead and Garth Reynolds discuss how the scope of practice is expanding as more pharmacists are being granted provider status and the authority to diagnose and prescribe for common ailments.  Reynolds explains that Illinois has recently passed legislation allowing pharmacists to prescribe birth control pills.  Snead shares how many states now allow pharmacist to test-&-treat for ailments such as strep throat, flu and, COVID.  
On the PBM front Reynolds explains that legislative and judicial wins are helping to reign in big PBM abuses.  More work needs to be done and both guests make their case for how and why more pharmacists should join and become more active in their state pharmacist association.  
Bruce Kneeland welcomes Rebecca (Becky) Snead, EVP & CEO, The National Alliance of State Pharmacy Associations (NASPA) and Garth Reynolds, Executive Director, Illinois Pharmacists Association
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Explore an Immersive Glimpse into the Future of Pharmacy | George Van Antwerp

The Future of Pharmacy: The future of pharmacy is being disrupted & we see the creation of transformative opportunities but with great challenges. How will the future of pharmacy take shape? As innovations in life sciences and new technology disrupt the health care value chain, consumers are increasingly focused on well-being, demanding greater health care access, convenience, and customized products. In this environment, exciting opportunities emerge for pharmacists to evolve and expand their role.
https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/future-of-pharmacy-disruption-opportunities-challenges.html
George Van Antwerp
Senior Manager, Deloitte Consulting LLP 
https://www.linkedin.com/in/vanantwerp/
George Van Antwerp is a leader in Deloitte Consulting’s Health Plan and Pharmacy practice where he works with clients on insights and analysis to improve their competitive positioning. Prior to joining Deloitte, George worked with inVentiv Health in their Medical Management business, and he led the pharmacy business for Silverlink Communications.  George also worked at Express Scripts where he focused on their consumer engagement solutions.  George holds an MBA and MA from Washington University in St. Louis and received his BS from the University of Michigan in Ann Arbor.
Discussion references:
Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789634/
Medical at Home: A Game-changing Opportunity for Long-Term Care
With 10,000 Americans aging into Medicare daily, some pharmacies have grown their market share by offering medical-at-home services to keep patients who might otherwise be in a nursing home in the familiarity of their homes longer.
https://ncpa.org/newsroom/qam/2021/06/08/qam-ed-medical-home-game-changing-opportunity-long-term-care
Thank you RxSafe for sponsoring this episode!
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Better Utilization of the Pharmacist’s Expertise | PGX for Pharmacists

How can we leverage pharmacists to help patients transition better and also allow the providers use the expertise of pharmacists?
According to the peer review journal JAMA (Journal of American Medical Association), to improve care when patients transition from a facility such as a hospital to their home, Medicare started reimbursing for what is called the Transition of Care in 2013. It still has a low adoption because the reimbursement is not as high and also takes resources such as staffing. 
Link to article mentioned: https://jamanetwork.com/journals/jama/fullarticle/2719292 
Dr. Chinki Bhatia completed her Master of Pharmacy from University of Sydney with a specialization in in-vitro fertilization. She was then awarded a scholarship from the University of Florida to complete her Ph.D. in Neuroscience. She acquired her Ph.D. while working on multiple projects and writing her dissertation on the role of cannabinoids in short-term memory. After seeing a need for personalized medicine, Dr. Bhatia added a pharmacogenomics certification to her educational resume in 2020. She Co-Founded her company Core Care Rx where she provides pharmacogenomics consultations, value based care services such as chronic care management along with Ayurvedic wellness consultations. She also serves as a preceptor to pharmacy students in Pharmacogenomics. 
Dipal Soni, PharmD, BCACP attended Ernest Mario School Of Pharmacy, Rutgers University and graduated with highest distinction. She pursued one year of pharmacy practice residency at Jersey Shore University Medical Center in NJ. During this time she worked alongside physicians in ambulatory clinics where she managed complex medications. Dr.Soni is a board certified ambulatory care pharmacist with major focus on transitions of care and counseling patents. Dr. Soni provided evidence driven recommendations and optimized pharmacotherapy. She was also a speaker in various support groups at the community hospital.
Thanks to Rx Safe for sponsoring this episode!
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Precision Medicine and Advocating for a Pharmacist in Every Physicians Office | The Public Health Pharmacist

Sue Paul is a pharmacist, entrepreneur and small business owner with over 20 years of experience in the industry.After journeying through the traditional pharmacy avenues of retail, nursing home consulting, and hospital, she founded SyneRxgy (pronounced si·nr·jee) Consulting LLC, a concierge pharmacy service that is registered as a Limited Category 2 Pharmacy in the State of Ohio. SyneRxgy assists patients and physicians in managing chronic disease states including medication adjustments and education, implementing and analyzing pharmacogenomic and nutrigenomic testing for patients, and compiling/reviewing current medication lists for patients. She enjoys educating clients on all aspects of medication to empower them to take control of their health. Current worksites include physician offices, employer worksites, and in-home patient visits.
In 2018, Sue co-founded PGx101 LLC, along with Dan Krinsky, RPh, MS, which offers pharmacists 20 hours of ACPE approved continuing education and a certificate in Pharmacogenomics (PGx). She has been using PGx in her clinic and with home patients to implement patient-centered medication modification in conjunction with their providers since 2016.
Sue is Co-Founder, along with Michelle Fritsch, PharmD, BCP, BCACP of Medipreneurs LLC, an international conference and community for pharmacy entrepreneurs. After a 2020 detour, planning is underway for their 3rd annual conference which will be held in Cincinnati, Oh October 2021. She gets a kick out of empowering other pharmacists to dream about how they would practice if there weren’t any barriers.
She is active in local, state and national professional organizations including board member and Vice President of the Ohio Pharmacists Foundation.
Recent awards include
• 2017 SCORE (Service Corps of Retired Executives) Client of the Year Award
• 2019 Top 25 Women Pharmacists of the Year according to Talk to Your
Pharmacist Pharmacy Advisory Group
• 2020 Upsher-Smith Excellence in Innovation Award by the Ohio Pharmacists
Association
Social Media Handles and Contact Information www.linkedin.com/in/sue-paulrph
@PGx101
@Medipreneurs
https://www.facebook.com/synerxgyconsulting/
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID-19: Does Medicinal Cannabis Help or Hurt? | CRx Podcast

Advances in research have led to increased interest in the properties and potential of cannabis to treat many illnesses that have alluded modern medicine. Now, practitioners and consumers turn their attention to the role that it may play in the treatment of COVID-19, the disease caused by the coronavirus SARS-CoV-2.
Special guests:
Jason Nelson | Senior Vice President, Horticulture
Marion McNabb, DrPH, MPH
Founder and President
Cannabis Center of Excellence, INC
The focus has been on the immune modulation and vascular effects of cannabis.1,2 As with any pharmacological treatment, the effects will depend on patient specifics and the stage of disease. To grasp the current state of research, CRx evaluates the weight of evidence and speaks with experts in the field of medicinal cannabis. When working with medicinal cannabis in the age of COVID-19, it may help to think in wo separate categories: COVID-19 naïve (cannabis use in a population that is not and has no record of having been infected by COVID-19) and acute COVID-19.
Can Using Cannabis Make People More Susceptible to COVID-19 Infection?
David Bearman, MD, executive vice president of the American Academy of Cannabinoid Medicine and a certified cannabinoid medicine specialist, notes that it’s important to distinguish between adult and medicinal cannabis use.
Concerning adult use, Bearman would err on the side of caution and recommends people “take an herbal vacation until they’ve been successfully vaccinated.” If a person is using cannabis to relieve symptoms of a serious illness, such as cancer or epilepsy, Bearman believes it may be beneficial for some patients to continue treatment but makes it clear that “risk assessment for cannabis during the COVID-19 pandemic needs to be made in conjunction with the health care provider on a case-by-case basis.”
The intent is to ensure that potential benefits outweigh the risks. Bearman also emphasizes that any inhalation—whether via smoking or vaporizing—increases a person’s risk of COVID-19 because the respiratory route of cannabis increases both sputum and bronchial irritation, making a person more susceptible to infection. Essentially, if cannabis is being used medicinally, clinicians should discuss the immune modulation effects and route of administration with patients.
Reference Links:
COVID study data will be released in August 2021 when the study is completed
Cannabis and COVID Research Event held by COE in Dec 2020 with 6 COVID and Cannabis Researchers
Link to sign up If companies are interested in partnering on the Healthcare provider medical cannabis study this year with COE and Medicinal Genomics
https://www.cannacenterofexcellence.org/CCOE on Facebook, Instagram, Twitter
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices